Palvella Therapeutics Inc

The current institutional shareholding score of Palvella Therapeutics Inc is 7.00, ranking 81 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 82.90%, representing a quarter-over-quarter increase of 1.50%. The largest institutional shareholder is Steven Cohen, holding a total of 94.53K shares, representing 0.62% of shares outstanding, with 0.86% increase in holdings.